Skip to main content
WHANIN PHARM CO.,LTD logo

WHANIN PHARM CO.,LTD — Investor Relations & Filings

Ticker · 016580 ISIN · KR7016580003 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2023-07-26 Director's Dealing
Country KR South Korea
Listing KO 016580

About WHANIN PHARM CO.,LTD

https://www.whanin.com/?lang=eng

WHANIN PHARM CO.,LTD. is a pharmaceutical company that develops, manufactures, and sells a range of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), with a particular focus on neuropsychiatric treatments such as anti-psychotics and CNS stimulants. In addition to its core CNS portfolio, Whanin Pharm's product line includes pharmaceuticals for the cardiovascular and gastrointestinal systems, antibiotics, and vitamin supplements. The company also provides development and manufacturing services for finished drug formulations.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by Whanin Pharmaceutical Co., Ltd. It details share acquisitions by an executive (Lee Kwang-sik) through open market purchases. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which falls under the 'Director's Dealing' category.
2023-07-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the acquisition of shares by major shareholders (Lee Gwang-sik and Lee Won-beom) of Whanin Pharmaceutical Co., Ltd., including the number of shares, percentage of ownership, and the purpose of the holding (influence on management). This type of filing is specifically categorized as a Major Shareholding Notification.
2023-07-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity's shareholding in a listed company crosses a specific threshold (typically 5%). The document details the shareholding changes of Fidelity Management & Research Company LLC in Hwanin Pharmaceutical Co., Ltd. This falls under the 'Major Shareholding Notification' category.
2023-06-08 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Whan In Pharm Co., Ltd. (환인제약(주)) covering the period from January 1, 2023, to March 31, 2023. It contains comprehensive financial statements, management discussion, and operational details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Hwanin Pharmaceutical. It provides key financial highlights (revenue, operating profit, net income) for the first quarter of 2023. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q1 2023
2023-04-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend declarations, and the election of board members/auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.